Physician profile
Daniela Jurevicius
NPI 1154804425
$1,297.05
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $607 · 2022: $358 · 2023: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $379.69 | 2021-2023 | |
| Nestle Healthcare Nutrition INC. | $133.56 | 2023 | |
| Novo Nordisk INC | $132.89 | 2021-2022 | |
| Lilly USA, LLC | $115.15 | 2021-2022 | |
| Glaxosmithkline, LLC. | $64.67 | 2021 | |
| Vanda Pharmaceuticals INC. | $56.29 | 2021 | |
| Abbott Laboratories | $50.35 | 2023 | Freestyle Libre 3 |
| Amgen INC. | $48.78 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.85 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.21 | 2021 | |
| Ambu INC. | $32.73 | 2022 | |
| Braintree Laboratories, INC. | $30.51 | 2022-2023 | Sutab |
| Esperion Therapeutics, INC. | $27.54 | 2021 | |
| Kci USA, INC. | $26.84 | 2023 | V.A.C. Veraflo Cleanse Choice |
| Astrazeneca Pharmaceuticals LP | $25.10 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $22.76 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.33 | 2021 | |
| Genentech USA, INC. | $18.29 | 2021 | |
| Amarin Pharma, INC. | $17.35 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Jurevicius listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.